Interferon lambda 4 genotype and pathway in alcoholic hepatitis.


Journal

Scandinavian journal of gastroenterology
ISSN: 1502-7708
Titre abrégé: Scand J Gastroenterol
Pays: England
ID NLM: 0060105

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 20 2 2021
medline: 19 8 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

Single nucleotide polymorphisms within the interferon lambda 4 ( In this pilot study, 58 patients with alcoholic hepatitis were genotyped for the Amongst the alcoholic hepatitis patients who died, the IFN negative patients live longer after diagnosis, and also the IFN negative patients tended to have an overall short-term survival benefit compared to IFN lambda positive patients ( The IFN lambda 4 pathway seems involved in the acute disease processes of alcoholic hepatitis and patients without IFN lambda expression seem to have a short-term survival benefit.

Identifiants

pubmed: 33602032
doi: 10.1080/00365521.2021.1874046
doi:

Substances chimiques

Antiviral Agents 0
IFNL4 protein, human 0
Interleukins 0
Interferons 9008-11-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

304-311

Auteurs

Sidsel Støy (S)

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Ewa Terczynska-Dyla (E)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Sanne Skovgård Veidal (SS)

Gubra, Hørsholm, Denmark.

Kristoffer Rigbolt (K)

Gubra, Hørsholm, Denmark.

Hendrik Vilstrup (H)

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Henning Grønbaek (H)

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Rune Hartmann (R)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Thomas D Sandahl (TD)

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH